Tipiracil hydrochloride是一种胸苷磷酸化酶 (TPase) 抑制剂，IC50 值为 35 nM，已用于转移性结直肠癌的联合治疗。

MT-DADMe-ImmA是一种化学稳定的类人MTAP过渡态的类似物，作为一种MTAP抑制剂，具有治疗人类头颈部和前列腺癌的潜力。

Trifluridine/tipiracil HCl mixture是一种口服抗肿瘤药物，通过抑制胸苷酸合成酶和掺入 DNA 显示抗肿瘤活性。

Tipiracil is a thymidine phosphorylase (TPase) inhibitor.

Doxifluridine是一种胸苷激酶激活剂，作用于PC9-DPE2细胞，IC50为0.62 μM。

CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose.

AVE5688 is an inhibitor of glycogen phosphorylase (GP), with IC50s of 430 nM and 915 nM and Kds of 170 nM and 530 nM for rabbit muscle glycogen phosphorylase (rmGPb and rmGPa, respectively); can be used for the research of type 2 diabetes.

CP 316819 is a selective glycogen phosphorylase inhibitor.

Ingliforib is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.